Search

everythinglearnresearchcommunity

for

Search:↓

The seed extract of Lepidium sativum L. can potentially treat hair loss, showing effects similar to 5% minoxidil.

There's a significant link between severe hair loss and metabolic syndrome in Saudi Arabia, suggesting early health checks could prevent future issues.

Male pattern baldness may indicate arterial stiffness in transgender men on long-term testosterone therapy.

Herpes gestationis is linked to certain antigens, atopic eczema affects T cell populations and may be eased by breastfeeding, higher doses of anti-androgen treatment can improve androgenic alopecia, topical minoxidil increases hair thickness, long-term methotrexate therapy can cause liver fibrosis in psoriasis patients, and Lichen Sclerosus et Atrophicus patients aren't at higher risk for autoimmune disorders.

Hormonal therapy like cyproterone acetate and spironolactone may help female hair loss, but more research is needed, especially for pre-menopausal women.

Early-stage male pattern baldness shows two types of hair loss: one on the top of the head linked to hormonal changes, and another at the back of the head. The top hair loss responds well to specific treatment, while the back hair loss does not.

Microneedles with traditional Chinese medicine can help regrow hair in androgenic alopecia.

AA–TF#15 significantly promotes hair regrowth and could be an effective treatment for androgenic alopecia.

Androgenic alopecia in men is mainly linked to family history, hormonal imbalances, and metabolic issues, but can also be influenced by lifestyle habits, environmental factors, and deficiencies in certain vitamins and microelements like copper.

PRP is more effective than minoxidil and placebo for treating hair loss.

Bioengineered nanoparticles can effectively treat hair loss by targeting specific enzymes and receptors.

People with androgenic alopecia (AGA) have a higher chance of getting metabolic syndrome.

The treatment led to denser, thicker hair growth and less hair loss.

Finasteride treatment for three years changes certain polyamine levels in the blood but not in urine.

Finasteride treats hair loss and reduces prostate cancer risk.

High testosterone to epitestosterone ratio in hair could predict male-pattern baldness.

Using anabolic-androgenic steroids can harm men's reproductive health and increase the risk of heart problems and death.

PRP shows promise for treating female hair loss but needs more research.

The study concluded that a higher waist-hip ratio significantly increases the risk of metabolic syndrome in women with PCOS.

Long-term anabolic steroid use can lead to heart and metabolic health issues.

Hair loss might be linked to eye aging due to inflammation markers in blood.

Testosterone increases heart and blood pressure issues in rats with endotoxemia, and stopping testosterone production can reduce these problems.

Women with excessive hair growth tend to have shorter index and ring fingers compared to others.

Mohamed Kandil suggests renaming Polycystic Ovary Syndrome to "Polyfollicular Anovulatory Androgenic Syndrome" to better describe its symptoms, but concerns exist that it may not cover all related issues like obesity and depression.

Fadrozole and Finasteride change frog sex ratios and cause intersex animals with altered gene expressions.

Transfersomes are better than liposomes for targeting hair follicles in alopecia treatment.

Eczema patients have a lower skin lipid to protein ratio, older and longer-staying hospital patients are more likely to get pressure ulcers, hair loss in AGA is linked to muscle degeneration, vitamin D deficiency is common in alopecia areata and linked to its severity, standard liver tests don't effectively detect fibrosis in psoriasis patients on methotrexate, and bullous pemphigoid patients have a higher death risk but combination therapy may reduce it.

The FAW-FS algorithm improves depression recognition, and psychological interventions help AGA patients' mental health.

Exemestane may protect bones by stimulating osteoblast growth through androgen-related pathways.